homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

June 24, 2021

Know Labs

Know Labs has been granted an additional patent for its Bio-RFID technology, growing its patent portfolio to 57 issued and pending patents. U.S. Patent No. 11,033,208 was issued by the United States Patent and Trademark Office and is titled “Fixed Operation Time Frequency Sweeps for an Analyte Sensor.” The patent relates to how operation of the Know Labs Bio-RFID sensor technology is controlled. Know Labs recently reported successful results from an independent pre-clinical study validating the company's Bio-RFID technology. This newly issued patent demonstrates the accuracy and sensitivity of the sensor, which is necessary for successful FDA clinical trials for the company's non-invasive blood glucose monitor. The Seattle-based company plans to file new patents regularly.




Email or user name:
Password:
 
Forgot password? Click here.